Evidence map›Paper›PMID 39840411›Full record

ReviewRecent patents on biotechnology2025

Carvacrol: Innovative Synthesis Pathways and Overview of its Patented Applications.

Reda El Boukhari, Ahmed Fatimi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Reda El BoukhariChemical Science and Engineering Research Team (ERSIC), Department of Chemistry, Polydisciplinary Faculty of Beni Mellal (FPBM), Sultan Moulay Slimane University (USMS), P.O. Box 592 Mghila, Beni Mellal 23000, Morocco.ORCID 0000-0002-4833-8540
Ahmed FatimiChemical Science and Engineering Research Team (ERSIC), Department of Chemistry, Polydisciplinary Faculty of Beni Mellal (FPBM), Sultan Moulay Slimane University (USMS), P.O. Box 592 Mghila, Beni Mellal 23000, Morocco.ORCID 0000-0001-8749-2009

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis research concerns the patentability of carvacrol; it could be helpful for researchers to easily identify any innovation in the biotechnological application of this monoterpene as well as other similar compounds.

backgroundLike thyme or oregano, several plants in the Lamiaceae family produce carvacrol. It is one of the secondary metabolites with several biological activities, including the improvement in plants' resistance and their protection. Carvacrol has many chemical properties, such as antioxidant and anti-microbial, which have made it interesting for multiple biotechnological applications in the fields of food, feed, pharmacology, and cosmetology.

objectiveWe have made an attempt to demonstrate the value of carvacrol, first by studying quantitative data from patent documents, and then, through some relevant patents, we have tried to highlight the various fields of innovation related to the properties of carvacrol.

methodsFor the study, we have collected and sorted patent documents (i.e., patent applications and granted patents) from specialized patent databases, using "carvacrol" and some of its synonyms as keywords. The selected documents have included these keywords in their titles, abstracts, or claims. Then, thanks to patent analysis, we have tried to provide an overview of the useful properties of organic compounds.

resultsWe have shown that about 90% of the patent documents studied have been published in the 2000s. The number of publications, which is constantly increasing, demonstrates the growing interest in carvacrol. Although the applications of carvacrol are varied, the data on the IPC classification show that most published innovations are concerned with formulations in the fields of health, food, and feed. The study of the most relevant patents has allowed us to highlight some developments in the extraction and synthesis of carvacrol and some examples of patents that illustrate the wide possibilities offered by the exploitation of carvacrol. Thus, we have discussed its use in the cosmetic, pharmaceutical, food, and agricultural fields.

conclusionCarvacrol is a natural compound with beneficial properties. Several applications using this monoterpene have already been patented in different fields. However, the evolution of patentability has grown this past year and revealed the potential of carvacrol in biotechnology.

Indexed as

CymenesMonoterpenesPatents as TopicAnti-Infective AgentsAntioxidantsBiotechnologyHumansAnti-Infective AgentsAntioxidantscarvacrolCymenesMonoterpenesbioactivitybiotechnology.CarvacrolinnovationLamiaceaepatent

Identifiers

PMID39840411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.